Glucohalal

Glucohalal is an oral preparation containing sodium hydrogen carbonate, potassium chloride, sodium chloride, and glucose. The product is marketed in the European Union, though specific strength and dosage form are not disclosed. It is presented without a brand name and is classified as a pharmaceutical compound with unknown therapeutic class. Glucohalal is intended for use under professional supervision, and its composition suggests potential roles in electrolyte and glucose supplementation.

Glucohalal is formulated with electrolyte salts and glucose, which may be considered in clinical situations that require supplementation of these components.

- Oral electrolyte replacement in mild dehydration. - Adjunctive glucose source for patients with low blood sugar under supervision. - Supportive care during gastrointestinal losses. - Temporary supplementation during fasting or pre‑operative preparation.

The safety profile of Glucohalal reflects the known effects of its individual ingredients.

Common: - Mild gastrointestinal discomfort such as nausea or bloating. - Transient increase in urinary output. - Slight alteration in taste perception.

Serious: - Hypernatremia or hyperkalemia in patients with impaired renal function. - Severe electrolyte imbalance leading to cardiac arrhythmia. - Allergic reaction including rash, itching, or swelling.

When considering Glucohalal, several precautionary measures should be observed to minimize risk.

- Assess renal and cardiac function before initiating therapy. - Monitor serum electrolytes regularly during use. - Avoid in individuals with known hypersensitivity to any component. - Use with caution in patients taking diuretics or antihypertensive agents. - Do not exceed the recommended volume without medical guidance. - Keep the product out of reach of children.

Glucohalal may interact with other medications or substances that affect electrolyte balance or glucose metabolism.

Avoid: - Concurrent use with high‑dose potassium supplements. - Combination with sodium‑rich intravenous fluids. - Co‑administration with medications that prolong the QT interval.

Use with caution: - Diuretics that alter sodium or potassium levels. - ACE inhibitors or ARBs that affect potassium homeostasis. - Insulin or oral hypoglycemic agents due to added glucose. - Antacids containing sodium bicarbonate.